High-Flow Nasal Cannula (HFNC)
High-Flow Nasal Cannula (HFNC) is a medical device with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism.
High-Flow Nasal Cannula Versus Noninvasive Ventilation After Extubation in Patients With COPD and Mild Hypercapnic Respiratory Failure
HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU
Ventilation Modalities and Acute Ischemic Stroke
High Flow Nasal Cannula in Severe Sepsis
Clinical Trials (6)
High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism.
High-Flow Nasal Cannula Versus Noninvasive Ventilation After Extubation in Patients With COPD and Mild Hypercapnic Respiratory Failure
HFNC Versus Conventional Oxygen Therapy in Prolonged Upper Gastrointestinal Endoscopy in the ICU
Ventilation Modalities and Acute Ischemic Stroke
High Flow Nasal Cannula in Severe Sepsis
Effects of High-Flow Nasal Cannula Therapy Assessed by Electrical Impedance Tomography
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6